+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Human Plasma Derivative Market - Global Forecast 2026-2032- Product Image
Human Plasma Derivative Market - Global Forecast 2026-2032- Product Image
Sale

Human Plasma Derivative Market - Global Forecast 2026-2032

  • Report

  • 182 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6282494
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Human Plasma Derivatives: Executive Overview

Human plasma derivatives are therapeutic products manufactured from donated human plasma and used across immunology, hematology, critical care, and replacement therapy. Their clinical importance reflects the limited availability of certain plasma-derived proteins and the need for dependable quality, traceability, and continuity of supply. The market is shaped by donation capacity, fractionation expertise, regulatory oversight, patient access, and healthcare-system resilience.

Supply Resilience and Regulatory Change Are Reshaping the Landscape

The landscape is being transformed by greater attention to plasma-collection infrastructure, donor recruitment, pathogen safety, and manufacturing redundancy. Regulators and healthcare providers increasingly emphasize end-to-end traceability, validated viral-reduction processes, cold-chain reliability, and transparent pharmacovigilance. At the same time, procurement organizations are balancing affordability with the clinical consequences of shortages, while manufacturers and health systems pursue more resilient sourcing and inventory practices.

Artificial Intelligence Strengthens Quality, Planning, and Patient Support

Artificial intelligence can improve plasma-derivative operations by identifying collection and manufacturing anomalies, supporting predictive maintenance, optimizing inventory allocation, and detecting potential supply disruptions earlier. In clinical settings, it may assist with patient identification, treatment monitoring, and evidence synthesis. Adoption remains dependent on validated data, cybersecurity, explainability, human oversight, and compliance with applicable medical-device, pharmaceutical, privacy, and good-manufacturing-practice requirements.

Regional Priorities Range from Collection Capacity to Access and Resilience

North America places strong emphasis on donation networks, advanced fractionation, regulatory compliance, and continuity planning. Latin America is focused on strengthening national blood systems, improving access, and reducing dependence on external supply. Europe combines rigorous quality standards with cross-border coordination and strategic attention to plasma sufficiency. The Middle East is developing specialized healthcare capacity while managing import dependence and logistics complexity. Africa’s priorities include blood-system investment, affordability, workforce development, and reliable distribution. Asia-Pacific presents diverse conditions, ranging from sophisticated manufacturing and clinical infrastructure to rapidly expanding collection, access, and regulatory capabilities.

Economic and Security Blocs Influence Procurement and Collaboration

ASEAN economies are navigating varied regulatory systems, healthcare capacity, and import requirements, creating opportunities for regional alignment and shared quality practices. BRICS members are emphasizing domestic capabilities, supply security, and broader access while facing substantial differences in infrastructure and regulation. The European Union benefits from coordinated standards and cross-border policy mechanisms, with continued attention to donor sufficiency and strategic autonomy. G7 countries prioritize high assurance, innovation, and resilience. GCC states are investing in advanced healthcare systems and centralized procurement, while NATO members increasingly view critical medical supply continuity as part of broader resilience planning.

Country Conditions Differ Across Donation, Manufacturing, and Access

Australia combines strong clinical standards with geographic distribution challenges. Brazil is strengthening public-health capacity while addressing regional inequality and supply dependence. Canada emphasizes quality, national coordination, and access across a large geography. China is expanding healthcare and biopharmaceutical capabilities under evolving regulatory oversight. France, Germany, Italy, and Spain operate within European quality and procurement frameworks while addressing plasma sufficiency and system efficiency. India is balancing expanding clinical demand with affordability, domestic capacity, and uneven access. Japan and South Korea combine advanced healthcare systems with aging-population pressures and supply-security priorities. Mexico is working to improve access and system capacity. Russia faces logistical, regulatory, and supply-chain considerations shaped by its healthcare environment. The United Kingdom is focused on national resilience, quality assurance, and dependable access. The United States has extensive collection and treatment infrastructure, with continued focus on donor recruitment, manufacturing reliability, and equitable patient access.

Industry Leaders Should Build Resilience Around Patients and Evidence

Leaders should diversify qualified collection and manufacturing capacity, strengthen donor-retention programs, and maintain risk-based inventories for clinically critical products. They should standardize data exchange across collection, testing, manufacturing, distribution, and treatment systems while validating artificial-intelligence tools before operational deployment. Partnerships with regulators, hospitals, patient organizations, and public-health agencies can improve shortage preparedness and responsible access. Investment decisions should prioritize documented clinical value, supply continuity, cybersecurity, workforce capability, and transparent quality metrics rather than volume expansion alone.

Methodology: Evidence-Led Synthesis of the Plasma-Derivative Ecosystem

This executive summary uses a structured qualitative assessment of the human plasma-derivative ecosystem. The framework considers clinical applications, plasma collection, fractionation and purification, quality and safety controls, regulation, procurement, distribution, healthcare access, digitalization, and regional resilience. Geographic comparisons are organized across the specified regions, economic and security groups, and countries. Conclusions are limited to established industry dynamics and do not present market estimates, market shares, forecasts, or company-specific claims.

Reliable Access Depends on Integrated System Performance

Human plasma derivatives remain dependent on a connected chain spanning donors, testing, manufacturing, regulation, logistics, and patient care. The most durable progress will come from combining rigorous safety systems with resilient supply planning, responsible technology adoption, and policies that expand equitable access. Organizations that coordinate these elements can better protect continuity of treatment while responding to changing clinical, regulatory, and geopolitical conditions.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Human Plasma Derivative Market, by By Product Type
7.1. Introduction
7.2. Albumin
7.2.1. 5% Albumin
7.2.2. 20% Albumin
7.3. Immunoglobulins
7.4. Coagulation Factors
8. Human Plasma Derivative Market, by By Product Nature
8.1. Introduction
8.2. Recombinant or Biotechnologically Derived
8.3. Plasma-Derived
9. Human Plasma Derivative Market, by By Application
9.1. Introduction
9.2. Hemophilia & Coagulation Disorders
9.3. Immunodeficiency Disorders
9.4. Burn & Trauma Care
9.5. Hypoalbuminemia
9.6. Cardiovascular Surgeries
10. Human Plasma Derivative Market, by By End-User
10.1. Introduction
10.2. Hospitals & Clinics
10.3. Specialty Treatment Centers
10.4. Blood Banks
11. Human Plasma Derivative Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Human Plasma Derivative Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Human Plasma Derivative Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. ADMA Biologics, Inc.
15.2. Baxter International Inc.
15.3. Bio Products Laboratory Limited
15.4. BioPharma Plasma LLC
15.5. Biotest AG
15.6. Boya BioTech Co., Ltd.
15.7. China Biologic Products Holdings, Inc.
15.8. China Resources Boya Bio-pharmaceutical Group Co., Ltd.
15.9. CSL Behring LLC
15.10. Emergent BioSolutions Inc.
15.11. Green Cross Corporation
15.12. Grifols S.A.
15.13. Hualan Biological Engineering Inc.
15.14. Intas Pharmaceuticals Ltd.
15.15. Kamada Ltd.
15.16. Kedrion S.p.A.
15.17. LFB Group S.A.
15.18. Octapharma AG
15.19. PlasmaGen BioSciences Pvt. Ltd.
15.20. Sanquin Blood Supply Foundation
15.21. Shandong Taibang Biological Products Co., Ltd.
15.22. Shanghai RAAS Blood Products Co., Ltd.
15.23. Shuanglin Bio-Technology Co., Ltd.
15.24. SK Plasma Co., Ltd.
15.25. Takeda Pharmaceutical Company Limited
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Human Plasma Derivative Market, Years Considered for the Study
FIGURE 2. Global Human Plasma Derivative Market, Research Design
FIGURE 3. Global Human Plasma Derivative Market, Research Framework
FIGURE 4. Global Human Plasma Derivative Market, Data Triangulation
FIGURE 5. Global Human Plasma Derivative Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Human Plasma Derivative Market Size, by By Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Human Plasma Derivative Market Size, by By Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Human Plasma Derivative Market Size, by By Product Nature, 2025 vs 2032 (%)
FIGURE 9. Global Human Plasma Derivative Market Size, by By Product Nature, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Human Plasma Derivative Market Size, by By Application, 2025 vs 2032 (%)
FIGURE 11. Global Human Plasma Derivative Market Size, by By Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Human Plasma Derivative Market Size, by By End-User, 2025 vs 2032 (%)
FIGURE 13. Global Human Plasma Derivative Market Size, by By End-User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Human Plasma Derivative Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Human Plasma Derivative Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Human Plasma Derivative Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Human Plasma Derivative Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Human Plasma Derivative Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Human Plasma Derivative Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Human Plasma Derivative Market Segmentation & Coverage
TABLE 2. Global Human Plasma Derivative Market Size, 2017-2032 (USD Million)
TABLE 3. Global Human Plasma Derivative Market Size, by By Product Type, 2017-2032 (USD Million)
TABLE 4. Global Albumin Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Albumin Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Albumin Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global 5% Albumin Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global 5% Albumin Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global 5% Albumin Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global 20% Albumin Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global 20% Albumin Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global 20% Albumin Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Immunoglobulins Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Immunoglobulins Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Immunoglobulins Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Coagulation Factors Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Coagulation Factors Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Coagulation Factors Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Human Plasma Derivative Market Size, by By Product Nature, 2017-2032 (USD Million)
TABLE 20. Global Recombinant or Biotechnologically Derived Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Recombinant or Biotechnologically Derived Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Recombinant or Biotechnologically Derived Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Plasma-Derived Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Plasma-Derived Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Plasma-Derived Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Human Plasma Derivative Market Size, by By Application, 2017-2032 (USD Million)
TABLE 27. Global Hemophilia & Coagulation Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Hemophilia & Coagulation Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Hemophilia & Coagulation Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Immunodeficiency Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Immunodeficiency Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Immunodeficiency Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Burn & Trauma Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Burn & Trauma Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Burn & Trauma Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Hypoalbuminemia Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Hypoalbuminemia Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Hypoalbuminemia Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Cardiovascular Surgeries Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Cardiovascular Surgeries Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Cardiovascular Surgeries Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Human Plasma Derivative Market Size, by By End-User, 2017-2032 (USD Million)
TABLE 43. Global Hospitals & Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Hospitals & Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Hospitals & Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Specialty Treatment Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Specialty Treatment Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Specialty Treatment Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Blood Banks Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Blood Banks Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Blood Banks Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Human Plasma Derivative Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Asia-Pacific Human Plasma Derivative Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Asia-Pacific Human Plasma Derivative Market Size, by By Product Type, 2017-2032 (USD Million)
TABLE 55. Asia-Pacific Human Plasma Derivative Market Size, by Albumin, 2017-2032 (USD Million)
TABLE 56. Asia-Pacific Human Plasma Derivative Market Size, by By Product Nature, 2017-2032 (USD Million)
TABLE 57. Asia-Pacific Human Plasma Derivative Market Size, by By Application, 2017-2032 (USD Million)
TABLE 58. Asia-Pacific Human Plasma Derivative Market Size, by By End-User, 2017-2032 (USD Million)
TABLE 59. North America Human Plasma Derivative Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. North America Human Plasma Derivative Market Size, by By Product Type, 2017-2032 (USD Million)
TABLE 61. North America Human Plasma Derivative Market Size, by Albumin, 2017-2032 (USD Million)
TABLE 62. North America Human Plasma Derivative Market Size, by By Product Nature, 2017-2032 (USD Million)
TABLE 63. North America Human Plasma Derivative Market Size, by By Application, 2017-2032 (USD Million)
TABLE 64. North America Human Plasma Derivative Market Size, by By End-User, 2017-2032 (USD Million)
TABLE 65. Latin America Human Plasma Derivative Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Latin America Human Plasma Derivative Market Size, by By Product Type, 2017-2032 (USD Million)
TABLE 67. Latin America Human Plasma Derivative Market Size, by Albumin, 2017-2032 (USD Million)
TABLE 68. Latin America Human Plasma Derivative Market Size, by By Product Nature, 2017-2032 (USD Million)
TABLE 69. Latin America Human Plasma Derivative Market Size, by By Application, 2017-2032 (USD Million)
TABLE 70. Latin America Human Plasma Derivative Market Size, by By End-User, 2017-2032 (USD Million)
TABLE 71. Europe Human Plasma Derivative Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Europe Human Plasma Derivative Market Size, by By Product Type, 2017-2032 (USD Million)
TABLE 73. Europe Human Plasma Derivative Market Size, by Albumin, 2017-2032 (USD Million)
TABLE 74. Europe Human Plasma Derivative Market Size, by By Product Nature, 2017-2032 (USD Million)
TABLE 75. Europe Human Plasma Derivative Market Size, by By Application, 2017-2032 (USD Million)
TABLE 76. Europe Human Plasma Derivative Market Size, by By End-User, 2017-2032 (USD Million)
TABLE 77. Middle East Human Plasma Derivative Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Middle East Human Plasma Derivative Market Size, by By Product Type, 2017-2032 (USD Million)
TABLE 79. Middle East Human Plasma Derivative Market Size, by Albumin, 2017-2032 (USD Million)
TABLE 80. Middle East Human Plasma Derivative Market Size, by By Product Nature, 2017-2032 (USD Million)
TABLE 81. Middle East Human Plasma Derivative Market Size, by By Application, 2017-2032 (USD Million)
TABLE 82. Middle East Human Plasma Derivative Market Size, by By End-User, 2017-2032 (USD Million)
TABLE 83. Africa Human Plasma Derivative Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Africa Human Plasma Derivative Market Size, by By Product Type, 2017-2032 (USD Million)
TABLE 85. Africa Human Plasma Derivative Market Size, by Albumin, 2017-2032 (USD Million)
TABLE 86. Africa Human Plasma Derivative Market Size, by By Product Nature, 2017-2032 (USD Million)
TABLE 87. Africa Human Plasma Derivative Market Size, by By Application, 2017-2032 (USD Million)
TABLE 88. Africa Human Plasma Derivative Market Size, by By End-User, 2017-2032 (USD Million)
TABLE 89. Global Human Plasma Derivative Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. ASEAN Human Plasma Derivative Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. ASEAN Human Plasma Derivative Market Size, by By Product Type, 2017-2032 (USD Million)
TABLE 92. ASEAN Human Plasma Derivative Market Size, by Albumin, 2017-2032 (USD Million)
TABLE 93. ASEAN Human Plasma Derivative Market Size, by By Product Nature, 2017-2032 (USD Million)
TABLE 94. ASEAN Human Plasma Derivative Market Size, by By Application, 2017-2032 (USD Million)
TABLE 95. ASEAN Human Plasma Derivative Market Size, by By End-User, 2017-2032 (USD Million)
TABLE 96. GCC Human Plasma Derivative Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. GCC Human Plasma Derivative Market Size, by By Product Type, 2017-2032 (USD Million)
TABLE 98. GCC Human Plasma Derivative Market Size, by Albumin, 2017-2032 (USD Million)
TABLE 99. GCC Human Plasma Derivative Market Size, by By Product Nature, 2017-2032 (USD Million)
TABLE 100. GCC Human Plasma Derivative Market Size, by By Application, 2017-2032 (USD Million)
TABLE 101. GCC Human Plasma Derivative Market Size, by By End-User, 2017-2032 (USD Million)
TABLE 102. European Union Human Plasma Derivative Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. European Union Human Plasma Derivative Market Size, by By Product Type, 2017-2032 (USD Million)
TABLE 104. European Union Human Plasma Derivative Market Size, by Albumin, 2017-2032 (USD Million)
TABLE 105. European Union Human Plasma Derivative Market Size, by By Product Nature, 2017-2032 (USD Million)
TABLE 106. European Union Human Plasma Derivative Market Size, by By Application, 2017-2032 (USD Million)
TABLE 107. European Union Human Plasma Derivative Market Size, by By End-User, 2017-2032 (USD Million)
TABLE 108. BRICS Human Plasma Derivative Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. BRICS Human Plasma Derivative Market Size, by By Product Type, 2017-2032 (USD Million)
TABLE 110. BRICS Human Plasma Derivative Market Size, by Albumin, 2017-2032 (USD Million)
TABLE 111. BRICS Human Plasma Derivative Market Size, by By Product Nature, 2017-2032 (USD Million)
TABLE 112. BRICS Human Plasma Derivative Market Size, by By Application, 2017-2032 (USD Million)
TABLE 113. BRICS Human Plasma Derivative Market Size, by By End-User, 2017-2032 (USD Million)
TABLE 114. G7 Human Plasma Derivative Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. G7 Human Plasma Derivative Market Size, by By Product Type, 2017-2032 (USD Million)
TABLE 116. G7 Human Plasma Derivative Market Size, by Albumin, 2017-2032 (USD Million)
TABLE 117. G7 Human Plasma Derivative Market Size, by By Product Nature, 2017-2032 (USD Million)
TABLE 118. G7 Human Plasma Derivative Market Size, by By Application, 2017-2032 (USD Million)
TABLE 119. G7 Human Plasma Derivative Market Size, by By End-User, 2017-2032 (USD Million)
TABLE 120. NATO Human Plasma Derivative Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. NATO Human Plasma Derivative Market Size, by By Product Type, 2017-2032 (USD Million)
TABLE 122. NATO Human Plasma Derivative Market Size, by Albumin, 2017-2032 (USD Million)
TABLE 123. NATO Human Plasma Derivative Market Size, by By Product Nature, 2017-2032 (USD Million)
TABLE 124. NATO Human Plasma Derivative Market Size, by By Application, 2017-2032 (USD Million)
TABLE 125. NATO Human Plasma Derivative Market Size, by By End-User, 2017-2032 (USD Million)
TABLE 126. Global Human Plasma Derivative Market Size, by Country, 2017-2032 (USD Million)
TABLE 127. United States Human Plasma Derivative Market Size, 2017-2032 (USD Million)
TABLE 128. United States Human Plasma Derivative Market Size, by By Product Type, 2017-2032 (USD Million)
TABLE 129. United States Human Plasma Derivative Market Size, by Albumin, 2017-2032 (USD Million)
TABLE 130. United States Human Plasma Derivative Market Size, by By Product Nature, 2017-2032 (USD Million)
TABLE 131. United States Human Plasma Derivative Market Size, by By Application, 2017-2032 (USD Million)
TABLE 132. United States Human Plasma Derivative Market Size, by By End-User, 2017-2032 (USD Million)
TABLE 133. Canada Human Plasma Derivative Market Size, 2017-2032 (USD Million)
TABLE 134. Canada Human Plasma Derivative Market Size, by By Product Type, 2017-2032 (USD Million)
TABLE 135. Canada Human Plasma Derivative Market Size, by Albumin, 2017-2032 (USD Million)
TABLE 136. Canada Human Plasma Derivative Market Size, by By Product Nature, 2017-2032 (USD Million)
TABLE 137. Canada Human Plasma Derivative Market Size, by By Application, 2017-2032 (USD Million)
TABLE 138. Canada Human Plasma Derivative Market Size, by By End-User, 2017-2032 (USD Million)
TABLE 139. Mexico Human Plasma Derivative Market Size, 2017-2032 (USD Million)
TABLE 140. Mexico Human Plasma Derivative Market Size, by By Product Type, 2017-2032 (USD Million)
TABLE 141. Mexico Human Plasma Derivative Market Size, by Albumin, 2017-2032 (USD Million)
TABLE 142. Mexico Human Plasma Derivative Market Size, by By Product Nature, 2017-2032 (USD Million)
TABLE 143. Mexico Human Plasma Derivative Market Size, by By Application, 2017-2032 (USD Million)
TABLE 144. Mexico Human Plasma Derivative Market Size, by By End-User, 2017-2032 (USD Million)
TABLE 145. Brazil Human Plasma Derivative Market Size, 2017-2032 (USD Million)
TABLE 146. Brazil Human Plasma Derivative Market Size, by By Product Type, 2017-2032 (USD Million)
TABLE 147. Brazil Human Plasma Derivative Market Size, by Albumin, 2017-2032 (USD Million)
TABLE 148. Brazil Human Plasma Derivative Market Size, by By Product Nature, 2017-2032 (USD Million)
TABLE 149. Brazil Human Plasma Derivative Market Size, by By Application, 2017-2032 (USD Million)
TABLE 150. Brazil Human Plasma Derivative Market Size, by By End-User, 2017-2032 (USD Million)
TABLE 151. United Kingdom Human Plasma Derivative Market Size, 2017-2032 (USD Million)
TABLE 152. United Kingdom Human Plasma Derivative Market Size, by By Product Type, 2017-2032 (USD Million)
TABLE 153. United Kingdom Human Plasma Derivative Market Size, by Albumin, 2017-2032 (USD Million)
TABLE 154. United Kingdom Human Plasma Derivative Market Size, by By Product Nature, 2017-2032 (USD Million)
TABLE 155. United Kingdom Human Plasma Derivative Market Size, by By Application, 2017-2032 (USD Million)
TABLE 156. United Kingdom Human Plasma Derivative Market Size, by By End-User, 2017-2032 (USD Million)
TABLE 157. Germany Human Plasma Derivative Market Size, 2017-2032 (USD Million)
TABLE 158. Germany Human Plasma Derivative Market Size, by By Product Type, 2017-2032 (USD Million)
TABLE 159. Germany Human Plasma Derivative Market Size, by Albumin, 2017-2032 (USD Million)
TABLE 160. Germany Human Plasma Derivative Market Size, by By Product Nature, 2017-2032 (USD Million)
TABLE 161. Germany Human Plasma Derivative Market Size, by By Application, 2017-2032 (USD Million)
TABLE 162. Germany Human Plasma Derivative Market Size, by By End-User, 2017-2032 (USD Million)
TABLE 163. France Human Plasma Derivative Market Size, 2017-2032 (USD Million)
TABLE 164. France Human Plasma Derivative Market Size, by By Product Type, 2017-2032 (USD Million)
TABLE 165. France Human Plasma Derivative Market Size, by Albumin, 2017-2032 (USD Million)
TABLE 166. France Human Plasma Derivative Market Size, by By Product Nature, 2017-2032 (USD Million)
TABLE 167. France Human Plasma Derivative Market Size, by By Application, 2017-2032 (USD Million)
TABLE 168. France Human Plasma Derivative Market Size, by By End-User, 2017-2032 (USD Million)
TABLE 169. Russia Human Plasma Derivative Market Size, 2017-2032 (USD Million)
TABLE 170. Russia Human Plasma Derivative Market Size, by By Product Type, 2017-2032 (USD Million)
TABLE 171. Russia Human Plasma Derivative Market Size, by Albumin, 2017-2032 (USD Million)
TABLE 172. Russia Human Plasma Derivative Market Size, by By Product Nature, 2017-2032 (USD Million)
TABLE 173. Russia Human Plasma Derivative Market Size, by By Application, 2017-2032 (USD Million)
TABLE 174. Russia Human Plasma Derivative Market Size, by By End-User, 2017-2032 (USD Million)
TABLE 175. Italy Human Plasma Derivative Market Size, 2017-2032 (USD Million)
TABLE 176. Italy Human Plasma Derivative Market Size, by By Product Type, 2017-2032 (USD Million)
TABLE 177. Italy Human Plasma Derivative Market Size, by Albumin, 2017-2032 (USD Million)
TABLE 178. Italy Human Plasma Derivative Market Size, by By Product Nature, 2017-2032 (USD Million)
TABLE 179. Italy Human Plasma Derivative Market Size, by By Application, 2017-2032 (USD Million)
TABLE 180. Italy Human Plasma Derivative Market Size, by By End-User, 2017-2032 (USD Million)
TABLE 181. Spain Human Plasma Derivative Market Size, 2017-2032 (USD Million)
TABLE 182. Spain Human Plasma Derivative Market Size, by By Product Type, 2017-2032 (USD Million)
TABLE 183. Spain Human Plasma Derivative Market Size, by Albumin, 2017-2032 (USD Million)
TABLE 184. Spain Human Plasma Derivative Market Size, by By Product Nature, 2017-2032 (USD Million)
TABLE 185. Spain Human Plasma Derivative Market Size, by By Application, 2017-2032 (USD Million)
TABLE 186. Spain Human Plasma Derivative Market Size, by By End-User, 2017-2032 (USD Million)
TABLE 187. China Human Plasma Derivative Market Size, 2017-2032 (USD Million)
TABLE 188. China Human Plasma Derivative Market Size, by By Product Type, 2017-2032 (USD Million)
TABLE 189. China Human Plasma Derivative Market Size, by Albumin, 2017-2032 (USD Million)
TABLE 190. China Human Plasma Derivative Market Size, by By Product Nature, 2017-2032 (USD Million)
TABLE 191. China Human Plasma Derivative Market Size, by By Application, 2017-2032 (USD Million)
TABLE 192. China Human Plasma Derivative Market Size, by By End-User, 2017-2032 (USD Million)
TABLE 193. India Human Plasma Derivative Market Size, 2017-2032 (USD Million)
TABLE 194. India Human Plasma Derivative Market Size, by By Product Type, 2017-2032 (USD Million)
TABLE 195. India Human Plasma Derivative Market Size, by Albumin, 2017-2032 (USD Million)
TABLE 196. India Human Plasma Derivative Market Size, by By Product Nature, 2017-2032 (USD Million)
TABLE 197. India Human Plasma Derivative Market Size, by By Application, 2017-2032 (USD Million)
TABLE 198. India Human Plasma Derivative Market Size, by By End-User, 2017-2032 (USD Million)
TABLE 199. Japan Human Plasma Derivative Market Size, 2017-2032 (USD Million)
TABLE 200. Japan Human Plasma Derivative Market Size, by By Product Type, 2017-2032 (USD Million)
TABLE 201. Japan Human Plasma Derivative Market Size, by Albumin, 2017-2032 (USD Million)
TABLE 202. Japan Human Plasma Derivative Market Size, by By Product Nature, 2017-2032 (USD Million)
TABLE 203. Japan Human Plasma Derivative Market Size, by By Application, 2017-2032 (USD Million)
TABLE 204. Japan Human Plasma Derivative Market Size, by By End-User, 2017-2032 (USD Million)
TABLE 205. Australia Human Plasma Derivative Market Size, 2017-2032 (USD Million)
TABLE 206. Australia Human Plasma Derivative Market Size, by By Product Type, 2017-2032 (USD Million)
TABLE 207. Australia Human Plasma Derivative Market Size, by Albumin, 2017-2032 (USD Million)
TABLE 208. Australia Human Plasma Derivative Market Size, by By Product Nature, 2017-2032 (USD Million)
TABLE 209. Australia Human Plasma Derivative Market Size, by By Application, 2017-2032 (USD Million)
TABLE 210. Australia Human Plasma Derivative Market Size, by By End-User, 2017-2032 (USD Million)
TABLE 211. South Korea Human Plasma Derivative Market Size, 2017-2032 (USD Million)
TABLE 212. South Korea Human Plasma Derivative Market Size, by By Product Type, 2017-2032 (USD Million)
TABLE 213. South Korea Human Plasma Derivative Market Size, by Albumin, 2017-2032 (USD Million)
TABLE 214. South Korea Human Plasma Derivative Market Size, by By Product Nature, 2017-2032 (USD Million)
TABLE 215. South Korea Human Plasma Derivative Market Size, by By Application, 2017-2032 (USD Million)
TABLE 216. South Korea Human Plasma Derivative Market Size, by By End-User, 2017-2032 (USD Million)
TABLE 217. Global Human Plasma Derivative Market Share, by Key Player, 2025
TABLE 218. Global Human Plasma Derivative Market, Key Experts

Companies Mentioned

  • ADMA Biologics, Inc.
  • Baxter International Inc.
  • Bio Products Laboratory Limited
  • BioPharma Plasma LLC
  • Biotest AG
  • Boya BioTech Co., Ltd.
  • China Biologic Products Holdings, Inc.
  • China Resources Boya Bio-pharmaceutical Group Co., Ltd.
  • CSL Behring LLC
  • Emergent BioSolutions Inc.
  • Green Cross Corporation
  • Grifols S.A.
  • Hualan Biological Engineering Inc.
  • Intas Pharmaceuticals Ltd.
  • Kamada Ltd.
  • Kedrion S.p.A.
  • LFB Group S.A.
  • Octapharma AG
  • PlasmaGen BioSciences Pvt. Ltd.
  • Sanquin Blood Supply Foundation
  • Shandong Taibang Biological Products Co., Ltd.
  • Shanghai RAAS Blood Products Co., Ltd.
  • Shuanglin Bio-Technology Co., Ltd.
  • SK Plasma Co., Ltd.
  • Takeda Pharmaceutical Company Limited

Related Reports

Animal Blood Plasma Products & Derivatives Market - Global Forecast 2026-2032 - Product Image

Animal Blood Plasma Products & Derivatives Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Blood Plasma Derivatives Market - Global Forecast 2026-2032 - Product Image

Blood Plasma Derivatives Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
Blood Plasma Derivatives Market Size, Share, Trends and Forecast by Type, Application, End User, and Region, 2026-2034 - Product Image

Blood Plasma Derivatives Market Size, Share, Trends and Forecast by Type, Application, End User, and Region, 2026-2034

  • Report
  • 147 Pages
  • Global
From
Blood Plasma Derivatives Market Report 2026 - Product Image

Blood Plasma Derivatives Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Bovine Blood Plasma Derivatives - Global Strategic Business Report - Product Image

Bovine Blood Plasma Derivatives - Global Strategic Business Report

  • Report
  • 289 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.